Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.

about

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.

P2860

Q26782583-82482260-4FB1-4DEB-9BE9-B0491DF29C10 Q37012876-9C3C2C7C-418E-419E-8A34-157450061FD9

P2860

Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.

Item

http://www.wikidata.org/entity/Q38077405

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targeting antitumor CD4 helper ...... telomerase for cancer vaccine.

@en

type

Item

label

Targeting antitumor CD4 helper ...... telomerase for cancer vaccine.

@en

prefLabel

Targeting antitumor CD4 helper ...... telomerase for cancer vaccine.

@en

P1476

Targeting antitumor CD4 helper ...... telomerase for cancer vaccine

@en

P2093

Christophe Borg

http://www.w3.org/2001/XMLSchema#string

Jeanne Galaine

http://www.w3.org/2001/XMLSchema#string

Laurent Beziaud

http://www.w3.org/2001/XMLSchema#string

Magalie Dosset

http://www.w3.org/2001/XMLSchema#string

Olivier Adotévi

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunotherapy: moving beyond current vaccines

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

Natural innate and adaptive immunity to cancer

The immune contexture in human tumours: impact on clinical outcome

Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine

Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.

CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

P304

1073-1077

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.23587

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yann Godet

P577

2013-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23357860

http://www.w3.org/2001/XMLSchema#string

P932

3899142

http://www.w3.org/2001/XMLSchema#string

Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.

about

P2860

P2860

Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932